NEUROENDOCRINE CARCINOMAS

Clinical trials for NEUROENDOCRINE CARCINOMAS explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CARCINOMAS trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for Tough-to-Treat cancer when standard therapy fails

Disease control Completed

This study tested whether adding the drug bevacizumab to standard chemotherapy (Folfiri) could help patients with aggressive neuroendocrine cancer live longer after their initial treatment stopped working. The trial involved 153 adults whose cancer had progressed despite first-li…

Matched conditions: NEUROENDOCRINE CARCINOMAS

Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control

Last updated Mar 10, 2026 12:52 UTC

NEUROENDOCRINE CARCINOMAS

Get alerted when new NEUROENDOCRINE CARCINOMAS trials appear

New hope for Tough-to-Treat cancer when standard therapy fails